Carafate Tablets 01
Carafate Tablet
Product Images NDC 58914-171
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carafate (NDC 58914-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carafate Tablets 03
Each Carafate tablet contains 1g sucralate and is used for treatment, dosage and administration as described in the corresponding material. It is advised to keep out of reach of children, and dispensers should use a light-resistant container with a resistant closure as the package is not child-resistant. This medicine should be stored at a controlled room temperature of 59.86°F (1530°C). It is distributed by Allergan, and Carafate is a registered trademark of Aptas Pharma Canada ULC, an Allergan company. All rights reserved. Allergan® and its design are trademarks of Allergan, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
